← SynDRA
LB42708
SynDRA canonical compound SYN1949912 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Mechanism of action | farnesyltransferase inhibitor |
Mechanisms of action (all sources)
- farnesyltransferase inhibitor
Cross-references
Synonyms
- LB-42708
- C30H27BrN4O2
- SCHEMBL6975755
- GTPL8029
- AOB5942
- MolPort-023-277-136
- HMS3653F07
- BCP09683
- ZINC1490366
- EX-A2090
- s7467
- 2507AH
- AKOS024458079
- SB19586
- NCGC00370772-05
- BC600547
- SW220047-1
- FT-0720438
- 4-[[1-[[1-[(4-Bromophenyl)methyl]-1H-imidazol-5-yl]methyl]-4-(1-naphthalenyl)-1H-pyrrol-3-yl]carbonyl]morpholine
- 4-[1-({1-[(4-bromophenyl)methyl]-1H-imidazol-5-yl}methyl)-4-(naphthalen-1-yl)-1H-pyrrole-3-carbonyl]morpholine
- (1-((1-(4-Bromobenzyl)-1H-imidazol-5-yl)methyl)-4-(naphthalen-1-yl)-1H-pyrrol-3-yl)(morpholino)methanone
- CHEMBL4210419
- CID 10099206
- [1-[[3-[(4-bromophenyl)methyl]imidazol-4-yl]methyl]-4-naphthalen-1-ylpyrrol-3-yl]-morpholin-4-ylmethanone
- BJA92939
- BDBM50453819
- CCG-270029
- AC-35927
- DA-33442
- HY-15879
- LB-42708; LB 42708
- E98939
- Q27079113
- (E)-N'-(2,4-dimethylphenyl)-N-((E)-((2,4-dimethylphenyl)imino)methyl)-N-methylformimidamide
- [1-[[1-[(4-Bromophenyl)methyl]-1H-imidazol-5-yl]methyl]-4-(1-naphthalenyl)-1H-pyrrol-3-yl]-4-morpholinylmethanone
Look up LB42708 in the interactive SynDRA portal →